Rationale: High-flow nasal cannula (HFNC) improves the clinical outcomes of nonintubated patients with acute hypoxemic respiratory failure (AHRF).
homogeneity by electrical impedance tomography. We enrolled 15 patients aged 60 6 14 years old with Pa O 2 /setFI O 2 130 6 35 mm Hg. Seven (47%) had bilateral lung infiltrates. Compared with the facial mask, HFNC significantly improved oxygenation (P , 0.001) and lowered respiratory rate (P , 0.01), DPes (P , 0.01), and pressure time product (P , 0.001). During HFNC, minute ventilation was reduced (P , 0.001) at constant arterial CO 2 tension and pH (P = 0.27 and P = 0.23, respectively); end-expiratory lung volume increased (P , 0.001), and tidal volume did not change (P = 0.44); the ratio of tidal volume to DPes (an estimate of dynamic lung compliance) increased (P , 0.05); finally, ventilation distribution was more homogeneous (P , 0.01).
Conclusions: In patients with AHRF, HFNC exerts multiple physiologic effects including less inspiratory effort and improved lung volume and compliance. These benefits might underlie the clinical efficacy of HFNC.
Keywords: high-flow nasal oxygen; electrical impedance tomography; esophageal pressure; acute lung injury High-flow nasal cannula (HFNC) is a noninvasive respiratory support designed to deliver 30-60 L/min of a heated, humidified mixture of air and oxygen through specifically designed nasal prongs (1) . HFNC was first used in preterm infants and pediatric patients (2) and recent large randomized clinical trials have promoted its use in adults with acute hypoxemic respiratory failure (AHRF) (3) . These trials demonstrated the potential of HFNC to improve clinical outcomes, such as reintubation rates and 90-day mortality (4-7). However, the physiologic mechanisms underlying the clinical benefits of HFNC are still poorly understood in adult patients with AHRF.
Basic clinical monitoring during HFNC therapy demonstrated rapid improvement of oxygenation and reduction of dyspnea in comparison with a standard facial mask (8, 9) . Findings in other populations (10) indicate that advanced respiratory monitoring might demonstrate other specific physiologic effects. A study in pediatric patients with acute bronchiolitis treated with HFNC showed reductions in inspiratory effort, as measured by esophageal pressure swings (11) , whereas in another study in patients with chronic obstructive pulmonary disease electrical impedance tomography (EIT) (12) suggested an increase in end-expiratory lung volume. Reduced inspiratory effort and improved lung volume might be particularly important in AHRF, because they may prevent respiratory muscle exhaustion and lower the VT/endexpiratory lung volume ratio, which are closely related to the need for intubation and the severity in these patients (13, 14) .
The present study describes the effects of HFNC on specific advanced physiologic parameters that may be correlated with clinical outcomes of patients with AHRF. Complementing standard clinical monitoring with the use of esophageal pressure and EIT, we assessed the effects of HFNC on gas exchange, patients' inspiratory effort, minute ventilation (MV), lung volume, dynamic compliance, transpulmonary pressure, and ventilation homogeneity. Our hypothesis was that HFNC significantly improves these key physiologic parameters.
Some of the data reported here have already been presented in the form of an abstract (15).
Methods
We enrolled 15 patients with AHRF admitted to the general intensive care unit of San Gerardo Hospital, Monza, Italy. Inclusion criteria were new or acutely worsening respiratory symptoms following a known clinical insult lasting less than a week, and Pa O 2 /setFI O 2 less than or equal to 300 mm Hg while receiving additional oxygen by a standard facial mask, as per clinical decision. Exclusion criteria are listed in the online supplement. The ethical committee of San Gerardo Hospital approved the study (reference number: 432_2015bis) and informed consent requirements were met according to local regulations.
At enrollment, we collected the patients' main demographics and clinical data. An esophageal balloon catheter was placed in the esophagus, as demonstrated by the appearance of cardiac artifacts and appropriate negative swings of pressure tracings during inspiration (16, 17) . Esophageal pressure waveforms were continuously recorded by a dedicated data acquisition system throughout the study. An EIT-dedicated belt was placed around each patient's chest and connected to a commercial EIT monitor. During the whole study, EIT data were registered at 20 Hz and stored for offline analysis by dedicated software (18) .
Each patient was entered in the two study phases with the same set FI O 2 for 20 minutes in computer-generated random order: standard nonocclusive oxygen facial mask with gas flow set at 12 L/min, and HFNC with gas flow 40 L/min. Set FI O 2 during both phases was selected clinically by the attending physician before enrollment to achieve peripheral saturation between 90 and 95% on pulse oximetry during standard oxygen facial mask breathing. Set FI O 2 during both study phases was measured by a dedicated system (AIRVO 2; Fisher and Paykel Healthcare, Auckland, New Zealand) connected to the standard facial mask or the nasal cannula. This system can deliver airflows between 2 and 60 L/min with FI O 2 between 0.21 and 1.0 by connection to a wall supply. FI O 2 is continuously measured at the gas outlet of the system. In summary, in keeping with previous studies (12, 19, 20) , we set the gas delivery system at 12 L/min during the facial mask phase and at 40 L/min during HFNC with the same measured set FI O 2 , obtained by modifying the additional oxygen wall supply. However, we could not avoid or verify lower tracheal and alveolar FI O 2 during the oxygen facial mask phase because of entrainment of room air.
At the end of each phase, we collected arterial blood gas analysis data, respiratory rates (RR), and hemodynamics. From the esophageal pressure waveforms recorded during the last 3-5 minutes of each phase we measured the following (21) (24) . The global inhomogeneity index gave a reliable and interpatient comparable synthetic assessment of inhomogeneous distribution of the VT in the lungs (24) . The risk of additional lung injury seems to increase linearly with inhomogeneous distribution of lung densities (25) , which is correlated with ventilation inhomogeneity (26) . Thus, any change in this index might be clinically significant. However, to our knowledge, no prospective clinical validation of specific thresholds has been done yet. 6. The global and regional peak inspiratory and expiratory airflows (PIF glob , PIF non-dep , and PIF dep ; PEF glob , PEF non-dep , and PEF dep , respectively) (27). 7. From the EIT-derived airflow tracings, we also measured the inspiratory (Ti) and expiratory (Te) times, and the total cycle time (Ttot) (28) .
Please note that all the lung volumes (e.g., VT) mentioned above were not measured but rather we assumed that the changes in chest electrical impedance reflect changes in lung volumes. We chose the sample size on the basis of previous studies (9-14, 16-20, 24) . For the sake of clarity, EIT measures (e.g., VT glob ) during HFNC were transformed from arbitrary units of impedance change to the percentage change from their baseline values during the oxygen facial mask phase. Normally distributed variables are expressed as mean 6 SD and were analyzed by a paired Student's t test. Nonnormally distributed variables are expressed as medians (interquartile range) and were compared by Wilcoxon signed rank test. Correlations were analyzed by Pearson coefficient. A level of P less than 0.05 (twotailed) was considered statistically significant.
Additional details on the method for this study are provided in the online supplement.
Results

Patients
Patients' main characteristics are reported in Table 1 During HFNC, DPes were significantly lower than with the standard nonocclusive oxygen facial mask (P , 0.01) ( Table 2 , Figure 1A ), indicating that patients had less inspiratory effort. Interestingly, the VT/DPes ratio (i.e., an estimate of the dynamic lung compliance) was significantly higher during HFNC (P , 0.05), possibly indicating external "ventilation support" by the mandatory flow of HFNC during inspiration, improved lung mechanics, or both. PTP and PTP min were both significantly lower with HFNC (P , 0.05 and P , 0.001), suggesting lighter metabolic work of breathing per breath and per minute (Table 2, Figure 1B ).
Effects of HFNC on Ventilation and Gas Exchange
MV was significantly lower during HFNC (P , 0.001) than with the standard nonocclusive oxygen facial mask (Table 2 ). This was caused by changes in RR or VT , which were inversely related (DRR 3 DVT: R 2 = 0.74, P , 0.001). On average, RR decreased (P , 0.01), whereas VT did not Figure 2B ). There was a significant correlation between the reductions in PTP and the changes of MV corr during HFNC (DPTP 3 DMV corr : R 2 = 0.46, P , 0.01), possibly indicating that enhanced CO 2 clearance by washout of the upper airways reduced the inspiratory work of breathing, that HFNC lowered CO 2 production, reducing the ventilation needs, or both. The relative reduction of PTP min passing from the oxygen facial mask to HFNC was significantly larger than the reduction of MV corr (32 6 12% vs. 18 6 15%; P , 0.05). The relative reductions of PTP min and RR passing from the mask to HFNC were not correlated (P = 0.147, data not shown).
Effects of HFNC on Lung Volume, Transpulmonary Pressures, Ventilation Homogeneity, and Airflows Lung volume, as measured by DEELI, significantly increased during HFNC, globally and in the dependent and nondependent lung regions (P < 0.01 for all) (Table 3, Figure 3A ). The increase in global gas content in the lungs was 51 6 57% of the baseline VT. This suggests the generation of positive end-expiratory pressure by HFNC that might have improved oxygenation and, in the presence of unchanged VT, reduced regional lung strain. Similarly, P L,ee and P L,ei increased during HFNC (P , 0.05) ( Table 2 ) and became less negative, possibly indicating a lower tendency to alveolar collapse (21) . Driving transpulmonary pressure fell during HFNC, although not significantly (P = 0.08) ( Table 2) .
The global inhomogeneity ventilation index fell slightly but significantly during HFNC (P , 0.01) ( Table 3) , indicating more homogeneous distribution of ventilation throughout the lungs, which might correspond to better distribution of lung densities (26) .
Patients' PEF decreased significantly overall, by the reduction of PEF from the dependent lung regions (Table 3 ) and this might be regarded as an indirect sign of improvement of lung compliance in this region. PIF was reduced during HFNC, although not significantly (P = 0.07) and this too might have contributed to improving oxygenation by giving higher alveolar FI O 2 . Finally, the Ti/Ttot ratio was lower during HFNC (P , 0.05) (Table 3) , which in presence of lower inspiratory effort and unchanged maximal inspiratory pressure suggests a lower tension-time index of the inspiratory muscles (28) .
Variables Associated with the Efficacy of HFNC
There was a significant correlation between DPes and PTP during HFNC and patients' baseline Pa CO 2 (R 2 = 0.433, P , 0.01 and R 2 = 0.275, P , 0.05, respectively) ( Figure 4 ; see Figure E1 in the online supplement). Baseline Pa O 2 was not correlated with lowering of either of these variables (P = 0.42 and P = 0.35, data not shown).
Discussion
The present study shows that in patients with AHRF, HFNC improves several key physiologic parameters including oxygenation, inspiratory effort, MV, RR and lung volume, dynamic lung compliance, transpulmonary pressure, and homogeneity.
Esophageal pressure swings and PTP are validated, commonly used measures of patients' inspiratory effort and metabolic work of breathing, respectively (21). Definition of abbreviations: CVP = central venous pressure; HFNC = high-flow nasal cannula; HR = heart rate; MAP = mean arterial pressure; DPes = inspiratory esophageal pressure swing; DP L = driving transpulmonary pressure; P L,ee = dynamic end-expiratory transpulmonary pressure; P L,ei = dynamic end-inspiratory transpulmonary pressure; PTP = pressure-time product per breath; PTP min = pressure time product per minute; RR = respiratory rate; SBP = systolic arterial blood pressure; set FI O 2 = FI O 2 clinically set before enrollment to obtain 90-95% peripheral oxygen saturation with standard facial mask (because the delivered flow was significantly higher during high-flow therapy, entrainment of room air was more likely with the standard facial mask and the FI O 2 reaching the trachea and conducting airways might have been higher during this phase); VT dep = tidal volume distending dependent regions; VT non-dep = tidal volume distending nondependent regions. Normally distributed variables are expressed as mean 6 SD, nonnormal ones as median (interquartile range). *P value by paired t test or by Wilcoxon signed rank test, as appropriate.
Previous studies described the reduction of work of breathing by HFNC in pediatric populations (11, 29 whereas the higher external flow coupled with lower inspiratory airflow during HFNC might have permitted minimal differences between set and alveolar FI O 2 (8) .
Improved lung volume, indicating positive end-expiratory pressure, might have contributed to the increase in the Pa O 2 /setFI O 2 ratio and the lower hypoxic drive too (30) . During HFNC, the MV needed to obtain normal arterial CO 2 tension was lower than with the facial mask and this might have followed enhanced CO 2 clearance by washout of upper airways (1, 8) , leading to lower ventilation needs and work of breathing. However, lower CO 2 production from the respiratory muscles (8), linked to the decrease in MV, may also have helped reduce the inspiratory effort and ventilation needs. The possible improvement in dynamic lung compliance might have established more favorable working conditions during inspiration and unloading of the inspiratory muscles. Among all these factors, the relation between the reduction in MV corr and changes in PTP suggests that better CO 2 clearance might have had a key role in reducing patients' work of breathing. However, this decrease was significantly larger than the reduction in MV corr , possibly indicating that multiple mechanisms work to reduce the workload. As a sign to clinicians, in this study the reduced inspiratory effort during HFNC positively correlated with higher baseline arterial CO 2 tension, suggesting HFNC was more effective in the presence of more severely impaired CO 2 clearance (e.g., in patients with AHRF with higher dead space fraction) (31) . The reduction of RR by HFNC was not related with that of PTP min . Previous findings linked this reduction of the RR to clinical success (32) but our result suggests that mechanisms besides reduced work of breathing underlie the clinical benefits of HFNC. The causal link between acute reductions of respiratory workload, long-term prevention of respiratory decompensation, reduced need of intubation, and improved survival seems reasonable but has yet to be proved. Another part of our findings suggests new hypotheses on the effects of HFNC on the physiologic determinants of ventilation-induced lung injury. We noted a decrease in driving transpulmonary pressure swings along inspiration. Additionally, absolute estimates of P L,ei and P L,ee were higher during the HFNC phase (as expected from the additional positive end-expiratory pressure effect), possibly resulting in a smaller tendency to lung collapse. As higher driving transpulmonary pressure and derecruitment (18, 21) potentially aggravate lung injury, HFNC might hypothetically lower this risk. Increased end-expiratory lung volume induced by HFNC with unchanged VT might have reduced lung strain, which seems linearly correlated with the severity of ventilation-induced lung injury (14) . Finally, the slight but significant decrease in the inhomogeneity of ventilation distribution indirectly suggests there may be fewer or smaller regional areas of alveolar collapse (26) , potentially reducing the risk of focal multiplication of the alveolar wall tension and additional injury (25) . In summary, our findings suggest that HFNC might affect key determinants of ventilationinduced lung injury, such as lung stress, strain, and inhomogeneity. There is lively debate on how to minimize the detrimental effects of spontaneous breathing on preexisting lung injury (33) (34) (35) and the hypotheses on the potential role of HFNC in improving physiologic determinants of ventilationinduced lung injury may well merit further scrutiny.
Our study has several limitations. First, EIT imaging covers only part of the lungs (approximately 50%); it cannot detect an increase of lung volume along the vertical axis unless an abdominal belt is used, and most of the validation studies of EIT compared with other techniques were conducted in different settings (i.e., intubated patients or animals). However, previous studies have showed linear correlations between EIT measurements of lung volume changes and those obtained by other validated methods (36, 37) , even in cases of significant changes in intrathoracic pressure (38) . Moreover, the randomized crossover design of this study (with each patient compared with herself or himself in the different phases) might have made the comparison of EIT measures more accurate. Second, the study phases were short; we aimed for the shortest time needed to equilibrate lung volumes and gas exchange given the difficulties of stable and reliable advanced respiratory monitoring in awake patients with AHRF. Third, we assessed only objective rather than subjective measures of dyspnea and did not investigate patients' comfort; however, subjective indexes have already been extensively reported (1, 8) .
Fourth, we assessed PTP by analyzing only the esophageal pressure tracings rather than the traditional PTPes that includes the chest wall static recoil pressure-time curve (39) because we lacked direct measure of chest wall compliance and absolute VT. However, in the two study phases, chest wall compliance was most probably unchanged and the VT measured by EIT did not vary, so changes in PTP should have been linearly correlated with changes in PTPes. Moreover, we calculated PTPes by using standard formula for chest wall compliance (21) and by calculation of absolute VT through an arbitrary milliliter/impedance unit conversion factor derived from the lower positive end-expiratory pressure phase of a previous study (38) and we found tight correlation with PTP (see the additional results section in the online supplement). Fifth, the population was small and this might have explained the lack of significance in some of the correlations. Finally, we measured only set FI O 2 and not that delivered to the lower airways, which might have differed, especially during the facial mask phase because of entrainment of room air. Thus, we cannot 
